---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-022762"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:25:41.998576+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Femasys appoints Kelley Nicholas as CCO; grants 100,000-share inducement option

## Summary
- Appointed Kelley Nicholas as Chief Commercial Officer effective June 17, 2025; she will lead U.S. commercialization and global partnerships.
- Nicholas brings over 25 years experience from NeuroPace, Hologic, Medtronic, Baxter, Intuitive Surgical.
- As inducement, Femasys granted option to purchase 100,000 shares vesting over 4 years (25% after 1 year, then 25% annually).
- Focus on expanding U.S. infertility market for FemaSeed and building international partnerships across full portfolio.

## SEC filing metadata
- accession: 0001140361-25-022762
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036125022762/0001140361-25-022762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036125022762/ef20050687_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-022762
- JSON: https://secwatch.observer/filing/0001140361-25-022762.json
- Plain text: https://secwatch.observer/filing/0001140361-25-022762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.